StockData

Aquestive Therapeutics vs Aytu BioPharma

AQST and AYTU side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AQST and AYTU compare

Aquestive Therapeutics is the larger company, worth 25 times as much as Aytu BioPharma ($491M against $19.3M).

Aquestive Therapeutics grew revenue faster over the last twelve months (12.5% versus −13.3% for Aytu BioPharma).

Aytu BioPharma keeps more of each dollar of sales as profit, with a net margin of −24.8% compared with −162% at Aquestive Therapeutics.

Aytu BioPharma scores higher on the StockData Score (9 against 3 for Aquestive Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAQSTAYTU
Size and price
Market cap$491M$19.3M
Share price$3.91$1.78
Change, 1 year−29.9%−13.6%
Change, 5 years−34.5%−95.6%
Beta (5Y)1.451.05
Employees14776
StockData Score
Total score39 (better)
Valuation score03 (better)
Growth score2 (better)0
Performance score03 (better)
Health score13 (better)
Dividend score00
Valuation
P/S10.0×0.3× (better)
P/B–0.5×
P/FCF–5.9×
FCF yield−8.3%16.8% (better)
Fair value–$8.51
Margin of safety–79.1%
Growth
Revenue growth (TTM)12.5% (better)−13.3%
Revenue growth, 5Y average−0.58% (better)−2.6%
Profitability
Gross margin65.3% (better)64.0%
Operating margin−114%−14.4% (better)
Net margin−162%−24.8% (better)
FCF margin−83.3%5.6% (better)
Return on equity–−52.6%
Return on invested capital–−63.5%
Financial health
Debt / equity–0.31
Interest coverage−5.4×−4.4× (better)
Current ratio6.12 (better)1.13
Altman Z-score−4.49−4.10 (better)
Piotroski F-score23 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions57.4%45.3%
Held by insiders3.2%15.1%
Insider net buying, 12 months−$2.3M–
Short interest, % of float24.1%3.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.